An elevated PSA reading has long put men in an uncomfortable position: it signals possible prostate cancer, but it is unreliable enough that acting on it often means an invasive biopsy that turns out ...

A new blood test may make it easier to detect the most dangerous forms of prostate cancer early. In a study from Karolinska Institutet, the Stockholm3 blood test detected more clinically significant ...

A new blood test may make it easier to detect the most dangerous forms of prostate cancer early on. In a study from Karolinska Institutet, the Stockholm3 blood test detected more clinically ...

A new review in Medical Oncology details how liquid biomarkers, advanced imaging, and artificial intelligence are transforming pre-biopsy discrimination of prostate cancer from benign disease.

Editor's note: This article was updated after the U.S. Food and Drug Administration approved the Galleri cancer test kit. When the Galleri test hit the market in 2021, it sounded enticing — it ...

Cleveland Diagnostics said this week that Michael Iskra is joining the company as its new CEO to accelerate commercial expansion of the IsoPSA prostate cancer assay. The company obtained Food and Drug ...

Forbes contributors publish independent expert analyses and insights. Joshua Cohen is a Boston-based writer who covers health policy. This voice experience is generated by AI. Learn more. This voice ...

NEW YORK, Sept. 8, 2026 /PRNewswire/ -- The Davos of Healthcare™ Summit, on September 14 in New York City, will proudly host the global launch of 5Q Spectra's Prostate Dx™, known as the "PSB" Blood ...

A new blood test could help doctors identify whether a treatment for advanced prostate cancer is failing weeks earlier than current tests, according to a U.K.-wide study led by UCL researchers. The ...